Vaxcyte Inc. (PCVX)
NASDAQ: PCVX
· Real-Time Price · USD
43.59
-0.35 (-0.80%)
At close: Oct 16, 2025, 3:59 PM
45.00
3.23%
After-hours: Oct 16, 2025, 07:36 PM EDT
-0.80% (1D)
| Bid | 41.95 |
| Market Cap | 5.66B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -547.5M |
| EPS (ttm) | -4.11 |
| PE Ratio (ttm) | -10.61 |
| Forward PE | -7.5 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 45 |
| Volume | 1,994,434 |
| Avg. Volume (20D) | 1,926,311.5 |
| Open | 43.86 |
| Previous Close | 43.94 |
| Day's Range | 42.80 - 44.35 |
| 52-Week Range | 27.66 - 118.54 |
| Beta | 1.12 |
| Ex-Dividend Date | n/a |
About PCVX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PCVX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PCVX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-5.7%
Shares of vaccine companies are trading lower foll...
Unlock content with
Pro Subscription
2 months ago
-9.06%
Vaxcyte shares are trading lower after the company reported a Q2 EPS miss.
